Page last updated: 2024-11-07

n-hydroxymethyl-n-methylformamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-hydroxymethyl-N-methylformamide: metabolite of dimethylformamide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107853
CHEBI ID5593
MeSH IDM0125076

Synonyms (17)

Synonym
20546-32-1
n-hydroxymethyl-n-methylformamide
hmmf
n-(hydroxymethyl)-n-methylformamide
AC1L32V8 ,
AKOS006273166
AC1Q6QNI ,
formamide, n-(hydroxymethyl)-n-methyl-
dmf-oh
CTK8H5291 ,
KOCFTADHOAAXFC-UHFFFAOYSA-N
n-formyl-n-hydroxymethyl-methylarnine
n-formyl-n-hydroxymethyl-methylamine
CHEBI:5593
n-(hydroxymethyl)-n-methyl-formamide
DTXSID90942723
Q27106817

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Comparison of the acute toxicity of DMF, DMF-OH and NMF shows that NMF is more toxic than DMF-OH, which is itself more toxic than DMF."( In vivo metabolism of dimethylformamide and relationship to toxicity in the male rat.
Lauwerys, R; Scailteur, V, 1984
)
0.27
"7 mmol/kg DMF, HMMF, or NMF showed i) that DMF is more toxic than HMMF or NMF, and ii) that hepatotoxicity occurs later for DMF than for HMMF or NMF."( Metabolism and hepatotoxicity of N,N-dimethylformamide, N-hydroxymethyl-N-methylformamide, and N-methylformamide in the rat.
Belpaire, FM; Buylaert, W; Rosseel, MT; Van den Bulcke, M; Wijnants, P, 1994
)
0.53
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
tertiary carboxamideA carboxamide resulting from the formal condensation of a carboxylic acid with a secondary amine; formula RC(=O)NHR(1)R(2).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (18.75)18.7374
1990's8 (50.00)18.2507
2000's3 (18.75)29.6817
2010's2 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.76 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]